SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-024894
Filing Date
2018-10-24
Accepted
2018-10-24 16:13:07
Documents
3
Period of Report
2018-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20181024.htm 8-K 24619
2 EX-99.1 srpt-ex991_6.htm EX-99.1 636400
3 GRAPHIC gqexgunibf04000001.jpg GRAPHIC 3151
  Complete submission text file 0001564590-18-024894.txt   666905
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 181136517
SIC: 2834 Pharmaceutical Preparations